Home / Registry / Record
Publishing rights & compliance · Illustrative record

Outlive

Health & Medicine · Publication and program dossier

By Peter Attia

Master file reference · illustrativeGPRCC-ILL-2023-PA-888625
Cover of Outlive by Peter Attia
Representative publication · edition may varyFind this edition ↗ (opens in a new tab)
Illustrative case statusApprovedScenario review date · 8 February 2023 – 7 February 2024 (release day unverified)
09Program records
33Review controls
0Open items

Master case overview

Master file reference
GPRCC-ILL-2023-PA-888625
Illustrative status
Approved
Author / reference identity
Peter Attia
Subject area
Health & Medicine
Work
Outlive
Review focus
Health evidence, reader framing and professional terminology. Program questions are selected for this subject area; no passage-level findings are asserted.
Proposed formats · scenario
Print and ebook
Proposed market scope · scenario
English-language release; foreign editions subject to separate review
Book release date
2023
Open Library ↗
Registration date · illustrative
8 January 2023 – 7 January 2024 (release day unverified)
Publication and registration basis
Outlive: Earliest dated catalog edition in the recorded first-publication year; editions may vary. The modeled registration is seven days after release. Where a source gives only a month or year, dates are shown as a range rather than inventing a day.
Modeled review date
8 February 2023 – 7 February 2024 (release day unverified)
Source basis
Library title, author, subject mapping and catalog program definitions; no manuscript examined.

Programs & status

This illustrative file covers 9 program records, 33 review controls and 0 open items. Select a program for its review details, document checklist and next action.

All requirements completed

All submitted documents are accepted in this scenario. No outstanding requirements remain.

33 / 33 completed
HMPCApproved

Health, Medical & Professional Claims Review

GPRCC-ILL-2023-PA-888625-HMPC

Review scope: evidence quality, professional review, reader framing.

3 review controls0 open items

Illustrative fee · USD$4,950

View review details ↓
FCRSApproved

Fact-Checking & Research Substantiation File

GPRCC-ILL-2023-PA-888625-FCRS

Review scope: claim inventory, data reproduction, correction control.

3 review controls0 open items

Illustrative fee · USD$5,800

View review details ↓
PFVRApproved

Professional / Author Credential Verification Record

GPRCC-ILL-2023-PA-888625-PFVR

Review scope: credential scope, verification sources, jurisdiction wording.

4 review controls0 open items

Illustrative fee · USD$3,300

View review details ↓
AEPCApproved

Advertising, Endorsement & Promotional Claims Review

GPRCC-ILL-2023-PA-888625-AEPC

Review scope: promotional claims, endorsement consent, material connections.

3 review controls0 open items

Illustrative fee · USD$4,150

View review details ↓
IMRCApproved

International Media & Reputation Clearance File

GPRCC-ILL-2023-PA-888625-IMRC

Review scope: fact and opinion boundaries, non-affiliation wording, interview preparation.

4 review controls0 open items

Illustrative fee · USD$4,950

View review details ↓
IDLCApproved

International Distribution & Licensing Compliance File

GPRCC-ILL-2023-PA-888625-IDLC

Review scope: license boundaries, retail metadata, accounting and reporting.

4 review controls0 open items

Illustrative fee · USD$5,800

View review details ↓
IRTCApproved

International Rights & Territory Control File

GPRCC-ILL-2023-PA-888625-IRTC

Review scope: chain of title, territory and format scope, quotation permissions.

3 review controls0 open items

Illustrative fee · USD$3,300

View review details ↓
CAVRApproved

Cover, Artwork & Visual Asset Rights Record

GPRCC-ILL-2023-PA-888625-CAVR

Review scope: visual asset provenance, designer permissions, format reuse.

5 review controls0 open items

Illustrative fee · USD$4,150

View review details ↓
IBEMApproved

International Brand Enforcement & Monitoring File

GPRCC-ILL-2023-PA-888625-IBEM

Review scope: protected assets, monitoring exclusions, control verification.

4 review controls0 open items

Illustrative fee · USD$5,100

View review details ↓
HMPC · Illustrative program record

Health, Medical & Professional Claims Review

Approved
Program reference
GPRCC-ILL-2023-PA-888625-HMPC
Master file
GPRCC-ILL-2023-PA-888625
Review scope
Print and ebook
Evidence position
3 of 3 controls complete in scenario
Publication context
Outlive by Peter Attia · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 3

  1. HMPC-102

    Evidence quality

    For the proposed scope of Outlive, record study type, limitations and relevance for claims selected for review. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  2. HMPC-103

    Professional review

    For the proposed scope of Outlive, define the qualifications and scope needed for a proposed specialist review. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  3. HMPC-104

    Reader framing

    For the proposed scope of Outlive, separate educational content from individualized advice. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 3

  • Clinical evidence appraisal worksheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: HMPC-102.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Specialist review briefCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: HMPC-103.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Reader information wording sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: HMPC-104.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
Maintenance standard. Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment. This is a modeled workflow, not a notice issued to the author.

↑ Back to programs

FCRS · Illustrative program record

Fact-Checking & Research Substantiation File

Approved
Program reference
GPRCC-ILL-2023-PA-888625-FCRS
Master file
GPRCC-ILL-2023-PA-888625
Review scope
Print and ebook
Evidence position
3 of 3 controls complete in scenario
Publication context
Outlive by Peter Attia · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 3

  1. FCRS-101

    Claim inventory

    For the proposed scope of Outlive, classify factual, historical and statistical claims selected for the review scope. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  2. FCRS-104

    Data reproduction

    For the proposed scope of Outlive, reconcile quoted figures with their source tables and units. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  3. FCRS-105

    Correction control

    For the proposed scope of Outlive, track the edition in which a proposed correction would take effect. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 3

  • Claim-to-source ledgerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: FCRS-101.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Statistical reproduction worksheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: FCRS-104.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Correction and version logCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: FCRS-105.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
Maintenance standard. Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment. This is a modeled workflow, not a notice issued to the author.

↑ Back to programs

PFVR · Illustrative program record

Professional / Author Credential Verification Record

Approved
Program reference
GPRCC-ILL-2023-PA-888625-PFVR
Master file
GPRCC-ILL-2023-PA-888625
Review scope
Print and ebook
Evidence position
4 of 4 controls complete in scenario
Publication context
Outlive by Peter Attia · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 4

  1. PFVR-101

    Credential scope

    For the proposed scope of Outlive, identify exactly which professional claims are proposed for author positioning. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  2. PFVR-102

    Verification sources

    For the proposed scope of Outlive, identify primary sources needed to verify each credential. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  3. PFVR-103

    Jurisdiction wording

    For the proposed scope of Outlive, distinguish academic qualifications from jurisdiction-specific practice rights. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  4. PFVR-105

    Currency checks

    For the proposed scope of Outlive, identify which professional claims need date-sensitive confirmation. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 4

  • Author credential claim inventoryCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: PFVR-101.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Credential verification checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: PFVR-102.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Professional title wording matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: PFVR-103.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Credential currency scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: PFVR-105.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
Maintenance standard. Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment. This is a modeled workflow, not a notice issued to the author.

↑ Back to programs

AEPC · Illustrative program record

Advertising, Endorsement & Promotional Claims Review

Approved
Program reference
GPRCC-ILL-2023-PA-888625-AEPC
Master file
GPRCC-ILL-2023-PA-888625
Review scope
Print and ebook
Evidence position
3 of 3 controls complete in scenario
Publication context
Outlive by Peter Attia · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 3

  1. AEPC-101

    Promotional claims

    For the proposed scope of Outlive, match proposed promotional language to documented support. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  2. AEPC-102

    Endorsement consent

    For the proposed scope of Outlive, check scope and permission for any proposed blurb or endorsement. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  3. AEPC-103

    Material connections

    For the proposed scope of Outlive, identify sponsorship disclosures that would be needed for the campaign. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 3

  • Advertising claim matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AEPC-101.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Endorsement permission checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AEPC-102.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Campaign disclosure scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: AEPC-103.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
Maintenance standard. Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment. This is a modeled workflow, not a notice issued to the author.

↑ Back to programs

IMRC · Illustrative program record

International Media & Reputation Clearance File

Approved
Program reference
GPRCC-ILL-2023-PA-888625-IMRC
Master file
GPRCC-ILL-2023-PA-888625
Review scope
Print and ebook
Evidence position
4 of 4 controls complete in scenario
Publication context
Outlive by Peter Attia · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 4

  1. IMRC-101

    Fact and opinion boundaries

    For the proposed scope of Outlive, separate editorial interpretation from independently checkable claims in proposed publicity. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  2. IMRC-102

    Non-affiliation wording

    For the proposed scope of Outlive, review references to people and institutions for unintended endorsement implications. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  3. IMRC-103

    Interview preparation

    For the proposed scope of Outlive, prepare source-backed responses and distinguish the author’s position from promotional paraphrases. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  4. IMRC-104

    Edition-specific publicity

    For the proposed scope of Outlive, align retailer summaries and campaign copy with the edition proposed for release. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 4

  • Publicity claim and source ledgerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IMRC-101.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Non-affiliation wording sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IMRC-102.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Interview and media briefingCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IMRC-103.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Campaign and jacket-copy comparisonCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IMRC-104.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
Maintenance standard. Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment. This is a modeled workflow, not a notice issued to the author.

↑ Back to programs

IDLC · Illustrative program record

International Distribution & Licensing Compliance File

Approved
Program reference
GPRCC-ILL-2023-PA-888625-IDLC
Master file
GPRCC-ILL-2023-PA-888625
Review scope
Print and ebook
Evidence position
4 of 4 controls complete in scenario
Publication context
Outlive by Peter Attia · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 4

  1. IDLC-102

    License boundaries

    For the proposed scope of Outlive, map term, format, territory, language and sublicensing limits. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  2. IDLC-103

    Retail metadata

    For the proposed scope of Outlive, reconcile title, author credit, edition description and rights-holder attribution. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  3. IDLC-104

    Accounting and reporting

    For the proposed scope of Outlive, document royalty reporting intervals, deductions and audit provisions. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  4. IDLC-105

    Termination controls

    For the proposed scope of Outlive, define takedown, stock sell-off and rights reversion responsibilities. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 4

  • Distribution license matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IDLC-102.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Retail metadata approval sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IDLC-103.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Royalty and reporting scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IDLC-104.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Termination and reversion checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IDLC-105.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
Maintenance standard. Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment. This is a modeled workflow, not a notice issued to the author.

↑ Back to programs

IRTC · Illustrative program record

International Rights & Territory Control File

Approved
Program reference
GPRCC-ILL-2023-PA-888625-IRTC
Master file
GPRCC-ILL-2023-PA-888625
Review scope
Print and ebook
Evidence position
3 of 3 controls complete in scenario
Publication context
Outlive by Peter Attia · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 3

  1. IRTC-101

    Chain of title

    For the proposed scope of Outlive, identify the party authorized to grant rights and reconcile contributor assignments. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  2. IRTC-102

    Territory and format scope

    For the proposed scope of Outlive, map languages, formats, exclusivity and reserved territories without assuming worldwide rights. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  3. IRTC-104

    Quotation permissions

    For the proposed scope of Outlive, record the basis for reuse of any third-party extracts in the proposed edition. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 3

  • Ownership and contributor assignment scheduleCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IRTC-101.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Territory, language and format matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IRTC-102.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Third-party permissions registerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IRTC-104.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
Maintenance standard. Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment. This is a modeled workflow, not a notice issued to the author.

↑ Back to programs

CAVR · Illustrative program record

Cover, Artwork & Visual Asset Rights Record

Approved
Program reference
GPRCC-ILL-2023-PA-888625-CAVR
Master file
GPRCC-ILL-2023-PA-888625
Review scope
Print and ebook
Evidence position
5 of 5 controls complete in scenario
Publication context
Outlive by Peter Attia · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 5

  1. CAVR-101

    Visual asset provenance

    For the proposed scope of Outlive, record the source and permitted use of cover and interior visual assets. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  2. CAVR-102

    Designer permissions

    For the proposed scope of Outlive, separate designer deliverables from third-party stock and font licenses. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  3. CAVR-103

    Format reuse

    For the proposed scope of Outlive, check proposed visual reuse across print, ebook, audio and promotion. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  4. CAVR-104

    Credit requirements

    For the proposed scope of Outlive, record mandatory image credits and license conditions. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  5. CAVR-105

    Edition approval

    For the proposed scope of Outlive, track the approved cover version for each proposed edition. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 5

  • Cover and artwork provenance registerCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: CAVR-101.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Designer and supplier rights checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: CAVR-102.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Visual reuse permission matrixCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: CAVR-103.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Visual credit-line sheetCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: CAVR-104.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Cover version approval logCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: CAVR-105.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
Maintenance standard. Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment. This is a modeled workflow, not a notice issued to the author.

↑ Back to programs

IBEM · Illustrative program record

International Brand Enforcement & Monitoring File

Approved
Program reference
GPRCC-ILL-2023-PA-888625-IBEM
Master file
GPRCC-ILL-2023-PA-888625
Review scope
Print and ebook
Evidence position
4 of 4 controls complete in scenario
Publication context
Outlive by Peter Attia · Health evidence, reader framing and professional terminology

Review controls and scoped outcome 4

  1. IBEM-101

    Protected assets

    For the proposed scope of Outlive, separate protectable text and artwork from third-party names and lawful references. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  2. IBEM-103

    Monitoring exclusions

    For the proposed scope of Outlive, exclude commentary, criticism and other lawful references from proposed monitoring. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  3. IBEM-104

    Control verification

    For the proposed scope of Outlive, identify who may authorize use of the proposed author and publication branding. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

  4. IBEM-105

    Notice readiness

    For the proposed scope of Outlive, specify evidence capture and rights-holder approval before any proposed notice. Apply this check in the context of health evidence, reader framing and professional terminology.

    Completed · scenario. Submitted evidence accepted; this requirement is completed within the scenario’s approved scope.

Completed requirements 4

  • Protected asset inventoryCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IBEM-101.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Monitoring keyword and exclusion planCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IBEM-103.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Brand and account control checklistCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IBEM-104.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
  • Evidence capture and escalation protocolCompletedSubmitted evidence accepted; this requirement is completed within the scenario’s approved scope. Reference: IBEM-105.Submission attempt 1 · 13 January 2023 – 12 January 2024 (release day unverified) · reviewed 8 February 2023 – 7 February 2024 (release day unverified) · illustrative
Maintenance standard. Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment. This is a modeled workflow, not a notice issued to the author.

↑ Back to programs

Evidence and document index

A modeled evidence schedule for Outlive. These are document requirements and scenario states, not uploaded attachments or manuscript citations.

Control referenceDocument requirementScenario state
HMPC-102Clinical evidence appraisal worksheetCompleted · submitted and reviewed
HMPC-103Specialist review briefCompleted · submitted and reviewed
HMPC-104Reader information wording sheetCompleted · submitted and reviewed
FCRS-101Claim-to-source ledgerCompleted · submitted and reviewed
FCRS-104Statistical reproduction worksheetCompleted · submitted and reviewed
FCRS-105Correction and version logCompleted · submitted and reviewed
PFVR-101Author credential claim inventoryCompleted · submitted and reviewed
PFVR-102Credential verification checklistCompleted · submitted and reviewed
PFVR-103Professional title wording matrixCompleted · submitted and reviewed
PFVR-105Credential currency scheduleCompleted · submitted and reviewed
AEPC-101Advertising claim matrixCompleted · submitted and reviewed
AEPC-102Endorsement permission checklistCompleted · submitted and reviewed
AEPC-103Campaign disclosure scheduleCompleted · submitted and reviewed
IMRC-101Publicity claim and source ledgerCompleted · submitted and reviewed
IMRC-102Non-affiliation wording sheetCompleted · submitted and reviewed
IMRC-103Interview and media briefingCompleted · submitted and reviewed
IMRC-104Campaign and jacket-copy comparisonCompleted · submitted and reviewed
IDLC-102Distribution license matrixCompleted · submitted and reviewed
IDLC-103Retail metadata approval sheetCompleted · submitted and reviewed
IDLC-104Royalty and reporting scheduleCompleted · submitted and reviewed
IDLC-105Termination and reversion checklistCompleted · submitted and reviewed
IRTC-101Ownership and contributor assignment scheduleCompleted · submitted and reviewed
IRTC-102Territory, language and format matrixCompleted · submitted and reviewed
IRTC-104Third-party permissions registerCompleted · submitted and reviewed
CAVR-101Cover and artwork provenance registerCompleted · submitted and reviewed
CAVR-102Designer and supplier rights checklistCompleted · submitted and reviewed
CAVR-103Visual reuse permission matrixCompleted · submitted and reviewed
CAVR-104Visual credit-line sheetCompleted · submitted and reviewed
CAVR-105Cover version approval logCompleted · submitted and reviewed
IBEM-101Protected asset inventoryCompleted · submitted and reviewed
IBEM-103Monitoring keyword and exclusion planCompleted · submitted and reviewed
IBEM-104Brand and account control checklistCompleted · submitted and reviewed
IBEM-105Evidence capture and escalation protocolCompleted · submitted and reviewed

Consolidated program status

ProgramIllustrative statusOpen itemsNext action
HMPCApproved0Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment.
FCRSApproved0Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment.
PFVRApproved0Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment.
AEPCApproved0Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment.
IMRCApproved0Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment.
IDLCApproved0Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment.
IRTCApproved0Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment.
CAVRApproved0Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment.
IBEMApproved0Maintain the documented scope. A new edition, rights grant or material campaign change would trigger reassessment.

Illustrative review history

Generated milestones showing how this workflow could progress; these events did not occur for the named author.

Scenario dateModeled milestone
8 January 2023 – 7 January 2024 (release day unverified)Registration modeled
13 January 2023 – 12 January 2024 (release day unverified)Evidence package submitted · scenario
25 January 2023 – 24 January 2024 (release day unverified)Submitted evidence reviewed · scenario
8 February 2023 – 7 February 2024 (release day unverified)Scoped approval modeled

Program fee breakdown

The original illustrative case total is allocated across the 9 programs below. These example amounts are not payment receipts or quotations.

ProgramProgram nameAllocated fee (USD)
HMPCHealth, Medical & Professional Claims Review$4,950
FCRSFact-Checking & Research Substantiation File$5,800
PFVRProfessional / Author Credential Verification Record$3,300
AEPCAdvertising, Endorsement & Promotional Claims Review$4,150
IMRCInternational Media & Reputation Clearance File$4,950
IDLCInternational Distribution & Licensing Compliance File$5,800
IRTCInternational Rights & Territory Control File$3,300
CAVRCover, Artwork & Visual Asset Rights Record$4,150
IBEMInternational Brand Enforcement & Monitoring File$5,100

Total illustrative fees · USD$41,500

These restored case allocations are separate from the planning bands for new quotes. A written scope and quote determine the charge for an actual matter.

Next steps

  1. Retain the edition, format and rights schedules modeled in this record.
  2. Check proposed changes against each program’s maintenance standard.
  3. Reassess new translations, licenses or substantial promotional changes before extending scope.

This sequence describes the modeled approved workflow only.

Record statements

Illustrative scope. The author and publication identify a library entry. Review details and registration milestones are synthetic; book publication dates are sourced; the page makes no claim that the author applied, supplied evidence, paid fees or received a determination.

Program references. GPRCC-ILL identifiers label scenarios, not statutory registrations. Document states and allocated fees are not proof of review or payment.

Publication context. The modeled status makes no finding about the publication’s legality, accuracy, ownership or suitability. Real determinations require a submitted record and an authorized review.

Author Case Library